Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Active-reference, Flexible-dose Study of Brexpiprazole in Patients With Acute Schizophrenia
Latest Information Update: 08 Mar 2022
At a glance
- Drugs Brexpiprazole (Primary) ; Quetiapine
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- Sponsors Lundbeck A/S
- 01 Mar 2022 Results evaluating the short- and long-term effects of brexpiprazole on patient functioning in schizophrenia using post hoc analysis of short and long term studies published in the Journal of Clinical Psychiatry
- 15 Sep 2020 Results of post hoc analysis assessing effect of brexpiprazole on patient engagement in patients with schizophrenia presented at the 33rd Annual Congress of the European College of Neuropsychopharmacology
- 01 Jan 2019 Results assessing the effect of the D2-receptor partial agonist brexpiprazole on prolactin, based on pooled data from NCT01396421, NCT01393613, NCT01810380, NCT01397786, NCT01810783, published in the Journal of Clinical Psychopharmacology.